Trends in prostate cancer survival in Sweden, 1960 through 1988: Evidence of increasing diagnosis of nonlethal tumors

Journal of the National Cancer Institute

Volumn 88, Issue 17, 1996, Pages 1216-1221

  Helgesen, Fred ^a,b   Holmberg, Lars ^c   Johansson, Jan Erik ^a,b   Bergström, Reinhold ^d,e   Adami, Hans Olov ^b,f  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c University Hospital   (Sweden)

^d University Hospital   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SURVIVAL; SWEDEN;

EID: 0029783325     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.17.1216     Document Type: Article

References (46)

1. Zaridze DG, Boyle P, Smans M. International trends in prostatic cancer. Int J Cancer 1984; 33:223-30.
2. Carter BS, Carter HB, Isaacs JT. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate 1990;16:187-97.
3. Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection [see comment citation in Medline]. J Natl Cancer Inst 1990;82:1624-8.
4. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol 1991;30:133-40.
5. Jones GW. Prostate cancer. Magnitude of the problem. American College of Surgeons data-base and epidemiologic study. Cancer 1993; 71:887-90.
6. Reynolds T. Prostate cancer rates climbed sharply in 1990 [news]. J Natl Cancer Inst 1993;85:947-8.
7. Levy IG, Gibbons L, Collins JP, Perkins DG, Mao Y. Prostate cancer trends in Canada: rising incidence or increased detection? [see comment citations in Medline]. Can Med Assoc J 1993;149:617-24.
8. Moller H, Friis S, Kjaer SK. Survival of Danish cancer patients 1943-1987. Male genital organs. APMIS Suppl 1993;33:122-36.
9. US Department of Health and Human Services/Public Health Service. Trends in prostate cancer - United States, 1980-1988. MMWR 1992;41:401-4.
10. Garfinkel L. Evaluating cancer statistics [editorial]. CA Cancer J Clin 1994;44:5-6.
11. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
12. National Board of Health and Welfare. Cancer incidence in Sweden 1991. Stockholm: Fritzes, 1994.
13. Lundberg S, Berge T. Prostatic carcinoma. An autopsy study. Scand J Urol Nephrol 1970; 4:93-7.
14. Guileyardo JM, Johnson WD, Welsh RA, Akazaki K, Correa P. Prevalance of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst 1980;65:311-6.
15. Franks L. Latent carcinoma of the prostate. J Pathol Bacteriol 1954;68:603-16.
16. Devesa SS, Silverman DT. Cancer incidence and mortality trends in the United States: 1935-1974. J Natl Cancer Inst 1978;60:545-71.
17. Cancer Registry of Norway. Survival of cancer patients. Cases diagnosed in Norway 1968-1975. Oslo: 1980.
18. Hakulinen T, Pukkala E, Hakama M, Lehtonen M, Saxen E, Teppo L. Survival of cancer patients in Finland in 1953-1974. Ann Clin Res 1981:13 Suppl 31:59-61.
19. Levi F, Randimbison L, Te VC, Franceschi S, La Vecchia C. Trends in cancer survival in Vaud, Switzerland. Eur J Cancer 1992;28A: 1490-5.
20. Stenbeck M, Rosen M. Cancer Survival in Sweden in 1961-1991. Acta Oncol 1995; Suppl 4:61-3.
21. Mattsson B. Cancer Registration in Sweden. Studies on completeness and validity of incidence and mortality registers. Ph.D. dissertation. Stockholm: University of Stockholm, Sweden, 1984.
22. Franzen S, Giertz G, Zajicek J. Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report. J Urol 1960;32:193-6.
23. Chodak GW, Bibbo M, Strauss FH 2d, Wied GL. Transrectal aspiration biopsy versus transperineal core biopsy for the diagnosis of carcinoma of the prostate. J Urol 1984;132: 480-2.
24. National Board of Health and Welfare. Cancer incidence in Sweden 1977, 1978 .... 1988 (annual publication). Stockholm: Fritzes, 1981, 1982.... 1991.
25. National Board of Health and Welfare. Cancer incidence in Sweden 1983. Stockholm: Fritzes, 1986.
26. Cutler S, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958;8:699-710.
27. Ederer F, Axtell I, Cutler S. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101-21.
28. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed 1985;19:197-207.
29. Statistics Sweden. Official statistics of Sweden (annual publications). Stockholm, Sweden.
30. Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Appl Stat 1987; 36:309-17.
31. Pocock S, Gore SM, Kerr GR. Long term survival analysis: the curability of breast cancer. Stat Med 1982;1:93-104.
32. Nomura AM, Kolonel LN. Prostate cancer: a current perspective. Epidemiol Rev 1991;13: 200-27.
33. Andersson SO, Wolk A, Giovannucci E, Bergstrom R, Lindgren C, Baron J, et al. Energy, nutrient intake and prostate cancer risk - a population based case-control study in Sweden. Int J Cancer. In press.
34. Adami HO, Bergstrom R, Engholm G, Wolk A, England A, Nyren O, et al. A prospective study of smoking and risk of prostate cancer. Int J Cancer. In press.
35. Carlsson P. Diffusion and economic effects of medical technology - in treatment of peptic ulcer, prostatic hyperplasia and gallbladder disease. Ph.D. dissertation. Linkoping: Linkoping University, 1987.
36. Byar DP. Proceedings: the Veterans' Administration Cooperative Urological Research Group's studies of cancer of the prostate. Cancer 1973;32:1126-30.
37. Gronberg H, Bergh A, Damber JE, Jonsson H, Lenner P, Angstrom T. Prostate cancer in northern Sweden. Incidence, survival and mortality in relation to tumour grade. Acta Oncol 1994;33:359-63.
38. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
39. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1 - The analysis of case-control studies. IARC Sci Publ 1980; 32:5-338.
40. Trasti H, Nilsson S, Peterson LE. Applied diagnostic techniques: a decisive factor in the long-term T-year survival rate in prostatic carcinoma. Br J Urol 1979;51:135-9.
41. Catalona WJ, Scott W. Carcinoma of the prostate. In: Walsh PC, Gittes RF, Perlmutter AD, Stamey TA, editors. Campbell's Urology. 5th ed. Philadelphia: Saunders, 1986:1474-6.
42. Johnson DE, Lanieri JP Jr, Ayala AG. Prostatic adenocarcinoma occurring in men under 50 years of age. J Surg Oncol 1972;4:207-16.
43. Cook GB, Watson FR. A comparison by age of death rates due to prostate cancer alone. J Urol 1968;100:669-71.
44. Smedley HM, Sinnott M, Freedman LS, Macaskill P, Naylor CP, Pillers EM. Age and survival in prostatic carcinoma. Br J Urol 1983;55:529-33.
45. Adami HO, Norlen BJ, Malker B, Meirik O. Long-term survival in prostatic carcinoma, with special reference to age as a prognostic factor. A nation-wide study. Scand J Urol Nephrol 1986;20:107-12.
46. Gronberg H, Damber JE, Jonsson H, Lenner P. Patient age as a prognostic factor in prostate cancer [see comment citation in Medline]. J Urol 1994;152:892-5.